Reishi mushroom (Ganoderma lucidum) has been used in traditional East Asian medicine for more than 2,000 years, where it was known as the “mushroom of immortality.” Today, it is one of the most studied functional mushrooms in the world, with a growing body of clinical and preclinical research focused specifically on its effects on the immune system. But what does the evidence actually show? Here is a clear-eyed look at the science.
What Makes Reishi Biologically Active?
Reishi contains several bioactive compound classes that researchers believe are responsible for its immune-modulating effects. The most studied are:
- Beta-glucans: Complex polysaccharides that interact with pattern recognition receptors on immune cells, particularly macrophages, dendritic cells, and natural killer (NK) cells.
- Triterpenoids (ganoderic acids): A group of over 100 lanostane-type triterpenes unique to Ganoderma species, with demonstrated anti-inflammatory and immunomodulatory properties in lab settings.
- Glycoproteins: Protein-polysaccharide complexes that appear to potentiate immune cell signaling.
The beta-glucan content is what primarily drives immune research, as these compounds bind to receptors like Dectin-1 and TLR-2, triggering downstream activation of innate and adaptive immune pathways.
What Clinical Trials Have Found
Most early research on reishi and immunity was conducted in cell cultures and animal models. Over the past decade, however, clinical trials have provided more direct evidence in humans.
T-Cell and Lymphocyte Modulation
A 2024 randomized controlled study published in a peer-reviewed nutrition journal examined the effects of Ganoderma lucidum dry extract on T lymphocyte function in older women. The researchers observed statistically significant changes in T-cell activation markers following supplementation, suggesting reishi may help counteract age-related immune decline.[1] This is particularly relevant because immune senescence, the gradual decline of immune competence with age, is a major driver of vulnerability to infection and reduced vaccine efficacy in older adults.
Beta-Glucan-Enriched Yogurt: A Randomized Trial
A 2018 randomized clinical trial evaluated immune modulation in participants who consumed yogurt enriched with beta-glucans derived from Ganoderma lucidum. The trial assessed pattern recognition receptor (PRR) activation and found that the reishi beta-glucans produced measurable immunomodulatory effects, including upregulation of innate immune markers.[2] The authors noted that PRR agonists, including mushroom-derived beta-glucans, hold promise for populations with immune immaturity or deficiency.
NK Cell Activity: The Most Cited Mechanism
Natural killer (NK) cells are front-line immune defenders: they identify and destroy virus-infected cells and abnormal cells without requiring prior sensitization. Multiple preclinical studies have shown that reishi polysaccharides can upregulate NK cell activity, increase cytokine output (particularly interferon-gamma and interleukin-2), and enhance macrophage phagocytosis.
In integrative oncology settings, reishi has been studied as a complementary intervention alongside conventional treatments. A 2020 narrative review covering medicinal mushrooms in integrative oncology noted that Ganoderma lucidum preparations have been observed to support NK cell function and reduce fatigue in cancer patients receiving chemotherapy, though the authors emphasized the need for larger, well-controlled trials before firm clinical recommendations can be made.[3]
Anti-Inflammatory Effects and Immune Regulation
Immune support is not simply about boosting immune output: it also means regulating the immune response to prevent excessive inflammation. Reishi’s triterpenoids appear to inhibit pro-inflammatory cytokines such as TNF-alpha and interleukins IL-1 and IL-6 in laboratory models, which has led some researchers to describe it as an immunomodulator rather than a straightforward immune stimulant.
This dual action, supporting immune activation when needed while dampening chronic inflammatory signaling, is one reason reishi is studied in autoimmune-adjacent research contexts. However, it is important to note that robust human clinical trials exploring these anti-inflammatory effects specifically are still relatively limited, and most mechanistic data comes from in vitro and animal studies.
What the Evidence Does NOT Show
Despite the promising research, several important caveats apply:
- Most human trials are small: Sample sizes in reishi clinical trials often range from 20 to 100 participants, which limits the statistical power and generalizability of findings.
- Standardization varies: “Reishi supplement” is not a uniform product. Whole fruiting body extracts, mycelium-based products, spore powders, and polysaccharide isolates all have different bioactive profiles. Results from one product cannot be automatically applied to another.
- No regulatory approval: Reishi is not approved by the FDA or equivalent bodies as a treatment for any immune condition. It is a dietary supplement, not a drug.
- Interaction potential: Reishi may interact with anticoagulant medications and immunosuppressant drugs. Anyone on such medications should consult a physician before use.
If you are evaluating supplement quality more broadly, our guide on how to read a mushroom supplement label covers what to look for in terms of beta-glucan content, extraction method, and third-party testing.
Choosing a Quality Reishi Supplement
For anyone interested in trying reishi, the research suggests looking for products made from the fruiting body (not mycelium on grain), with verified beta-glucan content through third-party testing. A 2024 study used a standardized Ganoderma lucidum dry extract in its human trial protocol, pointing toward the importance of extract standardization for reproducible results.
It is also worth noting that most clinical studies have used oral supplement forms rather than teas or tinctures, though these formats are popular. The bioavailability of different preparation methods remains an open research question.
Preventive health, including staying consistent with checkups and understanding your baselines, is increasingly recognized as critical for long-term wellbeing. A broader conversation about why people avoid healthcare and the cost of that avoidance is worth having: this piece on why many men don’t go to the doctor from Modern Men’s Health addresses some of those barriers directly.
Bottom Line
The clinical evidence for reishi as an immune-support supplement is more substantial than for many botanical supplements, particularly in the areas of T-cell modulation, NK cell activity, and beta-glucan-driven innate immune activation. That said, the research is still maturing: most studies are small, product standardization is inconsistent, and long-term safety data in healthy populations is limited.
Reishi is not a replacement for vaccines, medical care, or evidence-based treatments. But as a complementary tool for people interested in supporting immune resilience, especially older adults, the emerging clinical picture is genuinely encouraging.
References
- [1] Ganoderma lucidum dry extract supplementation modulates T lymphocyte function in older women. PubMed 38800991
- [2] Randomized Clinical Trial for the Evaluation of Immune Modulation by Yogurt Enriched with Beta-Glucans from Lingzhi or Reishi Medicinal Mushroom. PubMed 30317947
- [3] Significance of Medicinal Mushrooms in Integrative Oncology: A Narrative Review. PubMed 33424591
This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting any supplement.
